캔 파이트 바이오파마 (CANF)

Sep 03, 2025

Can-Fite BioPharma (NYSE:CANF) Given Buy Rating at D. Boral Capital - Defense World

Sep 03, 2025

Sep 02, 2025

Can swing trading help recover from Crane NXT Co. lossesMarket Growth Summary & AI Optimized Trade Strategies - Newser

Sep 02, 2025

Aug 30, 2025

Has FVRR formed a bullish divergence2025 Key Lessons & Low Risk High Win Rate Picks - Newser

Aug 30, 2025

Aug 29, 2025

Applying sector rotation models to Vale S.A. Depositary ReceiptJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser

Aug 29, 2025

Aug 28, 2025

Sentiment analysis tools applied to Vertical Aerospace Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser

Aug 28, 2025

Aug 27, 2025

Using RSI to spot recovery in ALDFUJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser

Aug 27, 2025

Aug 23, 2025

Fragrances Inc.Earnings Growth Report & Stepwise Swing Trade Plans - Newser

Aug 23, 2025

Aug 17, 2025

Full technical analysis of POST stockMarket Sentiment Summary & Breakout Confirmation Trade Signals - Newser

Aug 17, 2025

Aug 05, 2025

What indicators show strength in Enterprise Products Partners L.P. Limited PartnershipIn-Depth Stock Trading Volume Analysis - Newser

Aug 05, 2025

Jul 30, 2025

Can-Fite reaches 50% enrollment milestone in pancreatic cancer trial By Investing.com - Investing.com South Africa

Jul 30, 2025

Jul 30, 2025

Can-Fite reaches 50% enrollment milestone in pancreatic cancer trial - Investing.com

Jul 30, 2025

Jul 28, 2025

Can-Fite BioPharma prices $5 million public offering of ADSs - Investing.com

Jul 28, 2025

Jul 28, 2025

Can-Fite BioPharma prices $5 million public offering of ADSs By Investing.com - Investing.com India

Jul 28, 2025

May 27, 2025

Harbour Energy Begins First Oil Production From Maria Phase 2 - The Globe and Mail

May 27, 2025

Apr 25, 2025

Can Fite Biopharma stock hits 52-week low at $1.14 By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 25, 2025

Can Fite Biopharma stock hits 52-week low at $1.14 - Investing.com

Apr 25, 2025

Apr 14, 2025

Can Fite Biopharma stock hits 52-week low at $1.22 By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Can Fite Biopharma stock hits 52-week low at $1.22 - Investing.com

Apr 14, 2025

Apr 14, 2025

Can-Fite BioPharma announces $3M registered direct offering - Investing.com

Apr 14, 2025

Apr 14, 2025

Can-Fite’s Surging Stock: Is It Time to Act? - timothysykes.com

Apr 14, 2025

Dec 04, 2024

Can Fite Biopharma stock hits 52-week low at $1.86 - Investing.com

Dec 04, 2024

Oct 18, 2024

Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com

Oct 18, 2024

Aug 26, 2024

List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel

Aug 26, 2024

Apr 03, 2024

Can-Fite BioPharma seeks FDA nod for NASH drug trial - Investing.com

Apr 03, 2024

Nov 21, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 21, 2023

Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire UK

Jul 12, 2023

Nov 04, 2022

Pacira's (PCRX) Q3 Earnings Miss Estimates, Revenues Beat - Yahoo Finance

Nov 04, 2022

Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022

May 27, 2022

bioAffinity Technologies Inc Stock Price Today | NASDAQ: BIAF Live - Investing.com

May 27, 2022

Nov 30, 2020

Earnings Scheduled For November 30, 2020 - Yahoo Finance

Nov 30, 2020

Oct 14, 2020

4 Penny Stocks On Robinhood To Buy Under $4 Now; Worth The Risk? - Penny Stocks

Oct 14, 2020

Aug 24, 2019

10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance

Aug 24, 2019

Aug 02, 2016

Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha

Aug 02, 2016